Azenta, Inc. Reports First Quarter Fiscal 2026 Financial Results Detailing Continued Operations and Strategic Sales Azenta, Inc. announces its financial results for Q1 2026, highlighting revenue performance and strategic plans for discontinued operations. The report emphasizes ongoing initiatives and future growth outlook.

Azenta, Inc. Reports First Quarter Fiscal 2026 Financial Results Detailing Continued Operations and Strategic Sales #USA #Burlington,_Massachusetts #Azenta #Fiscal_2026 #B_Medical_Systems

Azenta Announces the Sale of B Medical Systems to THELEMA S.À R.L. Azenta, Inc. has agreed to sell its B Medical Systems business for $63 million to THELEMA S.À R.L., aiming to streamline operations and focus on core strengths.

Azenta Announces the Sale of B Medical Systems to THELEMA S.À R.L. #United_States #Burlington #Azenta #B_Medical_Systems #THELEMA

Azenta Inc. Reports Q3 Fiscal Year 2025 Financial Results and Outlook Azenta, Inc. delivers its financial results for the third quarter of 2025 and reiterates guidance for the full fiscal year, showcasing ongoing operational improvements.

Azenta Inc. Reports Q3 Fiscal Year 2025 Financial Results and Outlook #United_States #Burlington #Azenta #B_Medical_Systems #Nasdaq_AZTA